Cybin Inc N.CYBN

Alternate Symbol(s): CYBN

Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II. It has an intellectual property portfolio in the psychedelic drug development sector with over 30 patents granted and 160 patents pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands and Ireland.

NEO:CYBN - Post by User

Cybin Inc

<< Previous

Bullboard Posts

Next >>

Post by Clementsonon Jan 26, 2021 12:49pm

228 Views

Post# 32388292

Fueling the fire

Sponsored Post: Global CB market could soon be worth approximately $89 billion! Isn't that something good to look over for yourself? Legalization proposals could now be on track and this could just be a waiting game! Are these signs of the sprout of a massive industry?

Fueling all the possibilities, is the election of the new president, whom could be green leaf friendly. His pick of health and human secretary,Becerra seems to support it! With this stand, companies in production of cannabis could benefit. And also the people who have been waiting for it!

check disclaimer on profile and landing page.

<< Previous

Bullboard Posts

Next >>

@ the Bell: TSX advances to start off Christmas trading week